The FDA’s Cigarette Health Warning Rule Is Postponed to April 2023

• Respected FDA CGMP online training courses and programs for the pharmaceutical industry. 

U.S. Graphic Health Warnings Postponed Again

According to the article:

Source: FDA.gov

"The U.S. Food and Drug Administration has postponed the effective date of its “Required Warnings for Cigarette Packages and Advertisements” final rule to April 9, 2023, following a Feb. 10, 2022, ruling by the U.S. District Court for the Eastern District of Texas.

The move marks at least the fifth delay for graphic warning health warnings in the United States when counting previously set launch dates of June 18, 2021, Oct. 16, 2021, Jan. 14, 2022, April 14, 2022, and July 13, 2022."

Read the full source article:  U.S. Graphic Health Warnings Postponed Again - Tobacco Reporter

Learn more at: Cigarette Labeling and Health Warning Requirements - FDA.gov

Keywords & Phrases:
#FDA #CGMP #GMP

FDA Mandates Shocking Cigarette Smoking Images (video)

Beginning September 2012, FDA will require larger, more prominent cigarette health warnings on all cigarette packaging and advertisements in the United States, FDA Cigarette Health Warnings.

They're very much in your face, and on some gut level, pretty shocking, as this video shows:





Return Home: http://drughealth.blogspot.com/

Shocking FDA Images For Cigarette Packages

• FDA cGMP online training programs and courses by SkillsPlus International Inc.

Wow! These are high impact and jarring images. You have to check out what the FDA is proposing as new required warnings, consisting of nine new textual warning statements accompanied by color graphics depicting the negative health consequences of smoking, Proposed FDA Graphic Health Warnings for Cigarette Packages and Advertisements.

More Information:
FDA Proposed Cigarette Product Warning Labels

Return Home: http://drughealth.blogspot.com/

FDA Says Watch Out For Fake Alli Capsules

• FDA GMP QSR cGMP Online Training - GMP online training classes taught by SkillsPlus International Inc.

The U.S. Food and Drug Administration (FDA) is warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).  The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

• Outer cardboard packaging missing a “Lot” code;
• Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);
• Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;
• Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;
• Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Related Posts:
Counterfeits In The Global Drug Supply

Return Home: http://drughealth.blogspot.com/
The Health, Drug, Prescription, and GMP Supersite Gift Store 

FDA Website Redesigned

The FDA reports that "Through collaboration with users in testing site-wide designs, we made improvements to make FDA.gov easier and more satisfying to use." That may well be true as they describe their thinking on the redesign, About the FDA.gov Redesign - Why did FDA change its Website? Unfortunately, one unintended adverse effect impacts this blog. So, my apologies to folks who use and follow this blog . . . The FDA redesign has broken many links to FDA images, documents, and webpages. Here's to hoping they won't be redesigning the site again, any time soon. Peace.

Return Home: http://drughealth.blogspot.com/